Lexaria Bioscience Corp expected to post a loss of 11 cents a share - Earnings Preview

Lexaria Bioscience

12/01/2024 21:21

* Lexaria Bioscience Corp  LEXX.OQ   LEXX.O  is expected
to report
resultson January 15 (estimated) for the period ending November
30 2023
    * 
    * ​LSEG's mean analyst estimate for Lexaria Bioscience Corp
is for
a loss of 11 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lexaria
Bioscience Corp is $6.00​, above​ its last closing price
of $1.52. ​​​

This summary was machine generated January 12 at 21:20 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)